These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 8036134

  • 1. Contribution of bone marrow biopsy in the diagnosis and prognosis of polycythemia vera.
    de Mascarel A.
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):165-6. PubMed ID: 8036134
    [Abstract] [Full Text] [Related]

  • 2. The bone marrow in polycythemia vera.
    Ellis JT, Peterson P.
    Pathol Annu; 1979 Apr; 14 Pt 1():383-403. PubMed ID: 390480
    [Abstract] [Full Text] [Related]

  • 3. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
    Abdulkarim K, Ridell B, Johansson P, Kutti J, Safai-Kutti S, Andréasson B.
    Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
    [Abstract] [Full Text] [Related]

  • 4. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I, Galatâr N.
    Morphol Embryol (Bucur); 1989 Feb; 35(2):117-27. PubMed ID: 2529429
    [Abstract] [Full Text] [Related]

  • 5. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
    Thiele J, Kvasnicka HM, Zankovich R, Diehl V.
    Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
    [Abstract] [Full Text] [Related]

  • 6. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
    Ellis JT, Peterson P, Geller SA, Rappaport H.
    Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
    [Abstract] [Full Text] [Related]

  • 7. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
    Thiele J, Kvasnicka HM.
    Pathobiology; 2007 Apr; 74(2):89-96. PubMed ID: 17587880
    [Abstract] [Full Text] [Related]

  • 8. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R, Marzetta K, Miglioranza A, Redaelli S, Maino C, Maffiolini A, Gorini M.
    Recenti Prog Med; 2003 Apr; 94(7-8):314-20. PubMed ID: 12868237
    [Abstract] [Full Text] [Related]

  • 9. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A.
    Pathobiology; 2007 Apr; 74(2):97-114. PubMed ID: 17587881
    [Abstract] [Full Text] [Related]

  • 10. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
    Kvasnicka HM, Thiele J.
    Pathobiology; 2007 Apr; 74(2):63-71. PubMed ID: 17587877
    [Abstract] [Full Text] [Related]

  • 11. Myelofibrosis in the myeloproliferative disorders.
    Ellis JT, Peterson P.
    Prog Clin Biol Res; 1984 Apr; 154():19-42. PubMed ID: 6382293
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis of polycythemia vera based on bone marrow pathology.
    Thiele JM, Kvasnicka HM.
    Curr Hematol Rep; 2005 May; 4(3):218-23. PubMed ID: 15865875
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
    Thiele J, Kvasnicka HM, Vardiman J.
    Best Pract Res Clin Haematol; 2006 May; 19(3):413-37. PubMed ID: 16781481
    [Abstract] [Full Text] [Related]

  • 14. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP, Sanchez SR, Ewton AA, Rice L, Perkins SL, Dunphy CH, Chang CC.
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [Abstract] [Full Text] [Related]

  • 15. Bone marrow features of diagnostic impact in erythrocytosis.
    Thiele J, Kvasnicka HM, Diehl V.
    Ann Hematol; 2005 Jun; 84(6):362-7. PubMed ID: 15803315
    [Abstract] [Full Text] [Related]

  • 16. [Prognostic value of bone and bone marrow lesions of primary myeloid metaplasia].
    Chelloul N, Jacquillat C, Brière J, Laval-Jeantet M, Vorhauer-Atlan W.
    Nouv Presse Med; 1975 Dec 13; 4(43):3060-2. PubMed ID: 1223788
    [Abstract] [Full Text] [Related]

  • 17. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
    Michiels JJ, De Raeve H, Hebeda K, Lam KH, Berneman Z, Schroyens W, Schwarz J.
    Leuk Res; 2007 Aug 13; 31(8):1031-8. PubMed ID: 17367853
    [Abstract] [Full Text] [Related]

  • 18. Bone marrow histopathology in myeloproliferative disorders--current diagnostic approach.
    Thiele J, Kvasnicka HM, Orazi A.
    Semin Hematol; 2005 Oct 13; 42(4):184-95. PubMed ID: 16210032
    [Abstract] [Full Text] [Related]

  • 19. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population.
    Rudzki Z, Papla B, Stachura J.
    Pol J Pathol; 2004 Oct 13; 55(1):13-23. PubMed ID: 15195702
    [Abstract] [Full Text] [Related]

  • 20. [Polycythemia vera].
    Rain JD.
    Rev Prat; 2005 Oct 15; 55(15):1659-68. PubMed ID: 16334202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.